Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis
Clinical trial NCT03278314 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03278314
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.